The 0.75mg Wegovy Dose: What It Is and Why It Doesn't Appear in the Schedule

You've found 0.75mg Wegovy mentioned online and can't place it

This is a genuinely common moment of confusion. You've been reading about semaglutide, perhaps comparing pens, and 0.75mg keeps appearing. Here's the straightforward explanation: 0.75mg is a dose of Ozempic, not Wegovy. Both medicines contain semaglutide, but they are licensed for different things. Ozempic is prescribed for type 2 diabetes, in doses of 0.5mg and 1mg (and in some countries, 2mg). Its pen mechanism delivers in increments that produce a 0.75mg sub-step in certain contexts. Wegovy is licensed in the UK for weight management, in a completely separate dose ladder. The MHRA licenses each medicine individually, and semaglutide as a drug substance underpins both, but the products, the pens, the doses and the licensed uses are distinct. Treating yourself as though they're the same thing would be clinically incorrect, and any prescriber would tell you the same.

The confusion is understandable because some online discussions blend the two, especially on forums where people are comparing notes about doses. The safest approach is to go back to the product your prescriber actually prescribed, read the leaflet inside that specific pack, and ask if anything is unclear.

What the actual Wegovy dose schedule looks like in practice

Wegovy is introduced gradually, and there's a practical reason for that. Semaglutide slows how quickly food moves through the stomach. Starting at a full therapeutic dose would, for most people, produce significant nausea straight away. The licensed UK titration eases you in: 0.25mg for the first four weeks, then 0.5mg, then 1mg, then 1.7mg, reaching 2.4mg at around week seventeen if the earlier doses have been well tolerated. Your prescriber manages this, it's not something to adjust independently.

In January 2026 the MHRA approved a higher 7.2mg dose of Wegovy, and on 14 April 2026 a dedicated single-dose 7.2mg pen was cleared for adults with a BMI of 30 or above. That higher ceiling narrows the gap in average weight loss compared with tirzepatide, with trials reporting around 20.7% average reduction over 72 weeks. But even with the 7.2mg option now available, the titration still begins at 0.25mg. There are no shortcuts in the schedule, and moving from 0.5mg to 1mg still happens at the prescriber's discretion based on how you're tolerating treatment.

One quick habit worth building: before your next dose, check the label on your actual pen against your prescription. It takes thirty seconds and catches any pharmacy mix-up or confusion about which semaglutide product you've been sent.

Why Ozempic's 0.75mg context matters, and the licensing line you shouldn't cross

People sometimes ask whether they could use Ozempic for weight loss instead of Wegovy, since both contain semaglutide. The MHRA's position is clear: Wegovy is the semaglutide product licensed for weight management in the UK. Ozempic is licensed for type 2 diabetes. Prescribing Ozempic off-label for weight loss is not routine practice in the UK, and during periods of supply pressure the MHRA has specifically asked that Ozempic be prioritised for the diabetes patients it's licensed to treat.

The 0.75mg dose belongs firmly in the Ozempic/diabetes context. If a seller or website is offering 0.75mg semaglutide as a weight-loss product, that is a significant red flag. Legitimate UK pharmacies dispense Wegovy in its licensed strengths, sourced through the authorised supply chain, with a prescription from a registered prescriber. The frequently asked questions on our site cover more on how to spot a legitimate provider, but the GPhC register is always the starting point: you can verify any online pharmacy at pharmacyregulation.org.

For context on the cost of genuine Wegovy treatment through a regulated private pharmacy, our pricing overview explains what goes into the price and what's included.

If you're already on Wegovy and managing side effects at your current dose

GI side effects (nausea, loose stools, a reduced appetite that can tip into queasiness) are most noticeable when starting a new dose level, not usually at a fixed plateau. If you've recently moved up to 0.5mg or 1mg and are finding it difficult, the answer isn't to seek out an intermediate 0.75mg dose that doesn't exist. What does help is practical: smaller, lower-fat meals, keeping well hydrated, and giving your body the full titration window before pushing to the next step.

The NHS patient information for higher Wegovy doses covers managing ongoing side effects alongside treatment. If nausea is severe or persistent, that's a conversation for your prescriber, they may slow the titration or hold at the current dose for longer. For stomach upset specifically, questions about medicines like Imodium alongside semaglutide are common and worth reading about before reaching for the medicine cabinet. The NHS semaglutide guidance at nhs.uk/medicines/semaglutide has a clear rundown of common side effects and when they warrant medical attention.

If you'd like to talk through where you are in treatment, or you're weighing up whether Wegovy is the right option for you, checking your eligibility with our prescribers is a good place to start.